首页> 外国专利> 5-6-3-(4,5,6,7-TETRAHYDROPYRAZOLO4,3-CPYRIDIN-1-YL)AZETIDIN-1-YLMETHYLMORPHOLIN-4-YLQUINOLINE-8-CARBONITRILE DERIVATIVES AND SIMILAR COMPOUNDS AS TLR7-9 ANTAGONISTS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

5-6-3-(4,5,6,7-TETRAHYDROPYRAZOLO4,3-CPYRIDIN-1-YL)AZETIDIN-1-YLMETHYLMORPHOLIN-4-YLQUINOLINE-8-CARBONITRILE DERIVATIVES AND SIMILAR COMPOUNDS AS TLR7-9 ANTAGONISTS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

机译:5- [6 - [3-(4,5,6,7-四氢唑唑[4,3-C]吡啶-1-基)氮杂铂-1-基]甲基]吗啉-4-基]喹啉-8- 碳腈衍生物和类似化合物作为TLR7-9拮抗剂治疗系统性狼疮红斑狼疮

摘要

The present invention relates to a compound of formula (I) wherein R4 is C1-6alkyl, halogen or cyano; R5 is halogen; R2 is 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridinyl which is unsubstituted or substituted by C1-6alkyl or haloC1-6alkyl; 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridinyl which is unsubstituted or substituted one or two times by C1-6alkyl; or 5,6-dihydro-4H-pyrrolo[3,4-c]pyrazolyl; R3 is C1-6alkyl; L is azetidinyl or piperidinyl; or a pharmaceutically acceptable salt thereof, for use as a TLR7, TLR8 and/or TLR9 antagonist for the treatment or prophylaxis of autoimmune diseases, such as e.g. systemic lupus erythematosus or lupus nephritis.;
机译:本发明涉及式(I)化合物,其中R 4是C1-6烷基,卤素或氰基; R5是卤素; R 2是4,5,6,7-四氢吡唑[3,4-C]吡啶基,其未取代或被C1-6烷基或卤素1-6烷基取代; 4,5,6,7-四氢吡唑并[4,3-C]吡啶基,由C1-6烷基未取代或取代一或两次; 或5,6-二氢-4H-吡咯[3,4-C]吡唑基; R3是C1-6烷基; L是氮杂丁胺基或哌啶基; 或其药学上可接受的盐,用于用于治疗或预防自身免疫疾病的TLR7,TLR8和/或TLR9拮抗剂,例如例如,例如, Systemic Lupus红斑狼疮或狼疮性肾炎。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号